Congenital Bleeding Disorder

Hematology·MeSH: Hemophilia B

4 drugs in development·1 company·5 clinical trials

Drug Pipeline by Phase

Phase 3(4)

Drug	Company
nonacog beta pegol	Novo Nordisk A/S (NVO)
recombinant factor xiii	Novo Nordisk A/S (NVO)
turoctocog alfa	Novo Nordisk A/S (NVO)
turoctocog alfa pegol	Novo Nordisk A/S (NVO)

Compare drugs

nonacog beta pegol vs recombinant factor xiii nonacog beta pegol vs turoctocog alfa nonacog beta pegol vs turoctocog alfa pegol

Frequently asked questions

How many drugs are in development for Congenital Bleeding Disorder?

BioSniper tracks 4 drugs in development for Congenital Bleeding Disorder across 1 company.

How many clinical trials target Congenital Bleeding Disorder?

There are 5 clinical trials targeting Congenital Bleeding Disorder tracked by BioSniper.

Deep-dive into Congenital Bleeding Disorder

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis

Congenital Bleeding Disorder — Drugs in Development & Clinical Trials | BioSniper